Pillstats
Rx only · Capsule, Extended Release · Oral

Mesalamine

Brands: Apriso · Mesalamine

17 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
17 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA07EC02
RxCUI (US)52582
US makers17 labelers
Packages23
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.998$2.00$2.99$3.99Jun 2025Mar 2026Jul 2026
$0.782
Latest avg · Jul 22, 2026
-77%
Since Jun 18, 2025
17
Active US suppliers
26%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.8K9.6K14K19K2025 Q12025 Q22025 Q32025 Q42026 Q1
12K
Rx · 2026 Q1
1.7M
Units dispensed
-31%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it17 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown4SUPPLYING
Ascend Laboratories, LLCunknown2SUPPLYING
Sandoz Incunknown2SUPPLYING
Salix Pharmaceuticals, Inc.unknown2SUPPLYING
Mylan Pharmaceuticals Inc.unknown1SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
AvPAKunknown1SUPPLYING
Ingenus Pharmaceuticals, LLCunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown1SUPPLYING
Oceanside Pharmaceuticalsunknown1SUPPLYING
Zydus Lifesciences Limitedunknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING

+ 2 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 5, 2024
    RECALLRecall (Class II): Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical …

    Failed Dissolution Specifications: Out of specification for dissolution. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the U.S.